An idea gaining traction: Can measuring typing cadence help monitor and treat Parkinson’s Disease?

By SharpBrains | January 10, 2019

FDA grants break­through device des­ig­na­tion to Neu­raMetrix (press release): “The U.S. Food and Drug Admin­is­tra­tion (FDA) has grant­ed Break­through Device des­ig­na­tion to the Neu­raMetrix brain health mon­i­tor­ing solu­tion. The des­ig­na­tion is grant­ed for devices “that pro­vide more effec­tive treat­ment or diag­no­sis of life-threat­en­ing or irre­versibly debil­i­tat­ing human dis­ease or con­di­tions”. The approved use is monitoring…

Read More

Update: Why monitoring Typing Cadence may help detect early Parkinson’s and Alzheimer’s Disease

By SharpBrains | January 25, 2018

_____ Time for Sharp­Brains’ first eNewslet­ter in 2018, offer­ing a fas­ci­nat­ing sneek peek into the rapid­ly grow­ing toolk­it to mea­sure and improve brain health.  (And don’t miss the fun teas­er at the end!) New think­ing: Brain­no­va­tions Win­ner Jan Samzelius on why mon­i­tor­ing Typ­ing Cadence may help detect ear­ly Parkin­son’s and Alzheimer’s Dis­ease Firms Race to Find…

Read More

Jan Samzelius, CEO of Brainnovations Winner NeuraMetrix, encourages pioneers to focus on “simple, elegant solutions to big problems”

By Alvaro Fernandez | January 9, 2018

What sur­prised you the most from the Judges’ ques­tions and feed­back dur­ing the Brain­no­va­tions Pitch Con­test last month? Even with only a brief pre­sen­ta­tion the judges imme­di­ate­ly got the poten­tial impact of our tech­nol­o­gy to mea­sure and mon­i­tor brain health and began to think about oth­er appli­ca­tions for us – sev­er­al we had not thought about. That…

Read More